Science Technology

First dossier with CrisBio filed to EMA

Oct 26 2019
Science Technology

First Algenex CrisBio®-based vaccine submitted to European Medicines Agency

Oct 15 2019
Science Technology

Junta General Extraordinaria de socios

Jul 26 2019
Por acuerdo del Consejo de Administración de Alternative Gene Expression S.L. (en lo sucesivo “Algenex”) se convoca Junta General Extraordinaria de socios de Haizea, que tendrá lugar en Madrid, en las oficinas de Cleon Capital, Calle Serrano número 76 – 5 Izda., 28006 Madrid, el día 11 de septiembre de 2019, a las 17:00 horas.
Science Technology

Algenex and Global DX sign agreement to develop and commercialize diagnostic products for the detection of African Swine Fever

May 28 2019
Science Technology

ALGENEX supports development of recombinant biologics with €4m funding round

May 25 2019
Spanish biotechnology firm Algenex has progressed to its next stage of development after securing approximately €4 million ($4.5 million) in investment.
Science Technology

ALGENEX selected to present at the Animal Health Investment Innovation Showcase

Mar 22 2019
Animal Health Investment Europe is a premier international investment forum. The event was held on February 26th and 27th in London. More than 60 companies applied to participate in the Showcase, but only 24 were finalists, among whom was ALGENEX. The finalists, hand-picked by the Selection Committee, introduced themselves and their products/services on the main stage, in a quick-fire round of presentations. Claudia Jiménez, General Manager of ALGENEX, explained the CrisBio® technology, which consists in natural bio-reactors which have unique advantages for industrial production of any kind of recombinant protein, offering the most simple, cost-effective and scalable production technology up to date. CrisBio® has multiple advantages to obtain biotechnological high-tech products, with respect to classical production based on bioreactors.   Related links Animal Health Event CrisBio® technology
Science Technology

ALGENEX appoints new Strategic Advisory Board (SAB)

Mar 13 2019
Science Technology

ALGENEX closes funding round and strengthens team with key senior manager appointments

Mar 05 2019
Science Technology

BIOKIT licenses CRISBIO™ technology to make high quality recombinant proteins for in vitro diagnostics for human use

Mar 29 2017
Science Technology

ALGENEX has signed its first commercial license agreement with FATRO

Sep 08 2015